GlaxoSmithKline Pharma Q2 net dips 25% at Rs 96 crore

Standalone total income from operations also declined to Rs 700.09 crore for the quarter

GlaxoSmithKline Pharma Q2 net dips 25% at Rs 96 crore
Press Trust of India New Delhi
Last Updated : Oct 31 2015 | 3:35 PM IST
GlaxoSmithKline Pharmaceuticals today reported a 25.39% dip in standalone net profit at Rs 96.05 crore for the quarter ended September 30.

The company had posted a net profit of Rs 128.67 crore for the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.

Standalone total income from operations also declined to Rs 700.09 crore for the quarter under review as against Rs 746.76 crore for the corresponding period of previous fiscal.

Also Read

Established in 1924 in India, GlaxoSmithKline Pharmaceuticals product portfolio includes prescription medicines and vaccines.

The firm's prescription medicines range across therapeutic areas such as dermatology, anti-infectives, gynaecology, diabetes, cardiovascular diseases, respiratory diseases and oncology.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 31 2015 | 2:57 PM IST

Next Story